首页> 外文会议>International Conference on Cancer Care Informatics >The Link of Interferon Regulatory Factors 4 and 7 on the Patient’s Survival in Lung Adenocarcinoma
【24h】

The Link of Interferon Regulatory Factors 4 and 7 on the Patient’s Survival in Lung Adenocarcinoma

机译:干扰素调节因子4和7对患者在肺腺癌中生存的联系

获取原文

摘要

The mechanism behind the development and progression of cancer is complex and largely remained unknown. Recent studies suggest that interferon regulatory factors (IRF) 4 and 7 may play a significant role in carcinogenesis. Alterations on the expression profiles of the IRF4 and IRF7 directly induce pathogen susceptibility in the cell environment resulting in the activation of cancer-related factors required for a number of stages in metastatic cascade. In the present study, we have investigated the role of the IRF4 and IRF7 on the survival of patients with lung adenocarcinoma through genomics and interactome analyses using the data from The Cancer Genome Atlas (TCGA) database. In addition, the possible impact of the damaging mutations on the biological functions of the targeted proteins have been explored.
机译:癌症发展和进展背后的机制是复杂的,并且很大程度上仍然是未知的。最近的研究表明,干扰素调节因子(IRF)4和7可能在致癌作用中发挥重要作用。 IRF4和IRF7的表达谱的改变直接诱导细胞环境中的病原体易感性导致在转移级联中许多阶段所需的癌症相关因素的激活。在本研究中,我们研究了IRF4和IRF7在使用来自癌症基因组Atlas(TCGA)数据库的数据的基因组学和蛋白组分析肺腺癌患者的生存。此外,已经探讨了损伤突变对靶向蛋白质的生物功能的可能影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号